<SEC-DOCUMENT>0001415889-24-029472-index.html : 20241216
<SEC-HEADER>0001415889-24-029472.hdr.sgml : 20241216
<ACCEPTANCE-DATETIME>20241216161516
ACCESSION NUMBER:		0001415889-24-029472
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20241212
FILED AS OF DATE:		20241216
DATE AS OF CHANGE:		20241216

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Duncan Barbara Gayle
		CENTRAL INDEX KEY:			0001353128
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38085
		FILM NUMBER:		241551978

	MAIL ADDRESS:	
		STREET 1:		C/O INTERCEPT PHARMACEUTICALS, INC.
		STREET 2:		18 DESBROSSES STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ovid Therapeutics Inc.
		CENTRAL INDEX KEY:			0001636651
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				465270895
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		441 NINTH AVENUE, 14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10001
		BUSINESS PHONE:		212-776-4381

	MAIL ADDRESS:	
		STREET 1:		441 NINTH AVENUE, 14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10001
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-12162024_041213.xml
<TEXT>
Document 1 - file: form4-12162024_041213.html

Document 1 - RAW XML: form4-12162024_041213.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ex24-12162024_041213.htm
<TEXT>
Document 2 - file: ex24-12162024_041213.htm

</DOCUMENT>
</SEC-DOCUMENT>